β-Cell Pdx1 Expression Is Essential for the Glucoregulatory, Proliferative, and Cytoprotective Actions of Glucagon-Like Peptide-1

  1. Yazhou Li1,
  2. Xiemin Cao1,
  3. Li-Xin Li2,
  4. Patricia L. Brubaker12,
  5. Helena Edlund3 and
  6. Daniel J. Drucker1
  1. 1Department of Medicine, University of Toronto, The Banting and Best Diabetes Centre, The Toronto General Hospital, University of Toronto, Toronto, Canada
  2. 2Department of Physiology, University of Toronto, Toronto, Canada
  3. 3Umea Centre for Molecular Medicine, Umea University, Umea, Sweden
  1. Address correspondence and reprint requests to Dr. Daniel J. Drucker, Toronto General Hospital, BantingBest Diabetes Centre, 200 Elizabeth St., MBRW 4R402-2, Toronto, Canada M5G 2C4. E-mail: d.drucker{at}utoronto.ca

Abstract

Glucagon-like peptide-1 (GLP-1) regulates energy intake, gastrointestinal motility, and nutrient disposal. The relative importance of the islet β-cell for GLP-1 actions remains unclear. We determined the role of the islet β-cell and the pancreatic duodenal homeobox-1 (Pdx1) transcription factor for GLP-1 receptor (GLP-1R)-dependent actions through analysis of mice with β-cell–specific inactivation of the Pdx1 gene (β-cellPdx1−/− mice). The GLP-1R agonist exendin-4 (Ex-4) reduced glycemic excursion following intraperitoneal (i.p.) glucose challenge in control littermates (β-cellPdx1+/+ mice) but not in β-cellPdx1−/− mice. Similarly, Ex-4 failed to increase levels of plasma insulin, pancreatic insulin content, and pancreatic insulin mRNA transcripts in β-cellPdx1−/− mice. Furthermore, Ex-4 significantly increased β-cell proliferation and reduced β-cell apoptosis in β-cellPdx1+/+ mice but not in β-cellPdx1−/− mice. Moreover, Ex-4 increased the levels of insulin and amylin mRNA transcripts and augmented glucose-stimulated insulin secretion in islets from β-cellPdx1+/+ mice but not in β-cellPdx1−/− islets. Surprisingly, Ex-4 failed to reduce levels of plasma glucagon in β-cellPdx1−/− mice. These findings demonstrate that Pdx1 expression is essential for integrating GLP-1R–dependent signals regulating α-cell glucagon secretion and for the growth, differentiated function, and survival of islet β-cells.

Footnotes

  • H.E. is cofounder of and shareholder in Betagenon, Sweden. D.J.D. is a consultant to Amylin and Eli Lilly and is on Amylin’s science advisory board.

    Ex-4, exendin-4; GLP-1, glucagon-like peptide-1; GLP-1R, GLP-1 receptor; IBMX, 3-isobutyl-1-methylxanthine; IPGTT, intraperitoneal glucose tolerance test; KRB, Krebs-Ringer bicarbonate; OGTT, oral glucose tolerance test; Pdx1, pancreatic duodenal homeobox-1.

    • Accepted November 5, 2004.
    • Received August 12, 2004.
« Previous | Next Article »Table of Contents